Novo Nordisk A/S (NOV1)
Market Closed
3 Jun, 20:00
XFRA XFRA Primary 
NEO-L €
10. 60
-0.3
-2.75%
€
48.29B Market Cap
48.26 P/E Ratio
0.32% Div Yield
0 Volume
0 Eps
€ 10.9
Previous Close Want to track NOV1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novo Nordisk A/S (NOV1) Statistics
Valuation metrics
Market Cap 48.29B
Enterprise value 23.35B
Trailing P/E (ttm) 2.97
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 0.15
Price/Book (mrq) 1.78
Enterprise Value/Revenue 0.53
Enterprise Value/EBITDA 1
Overview
Shares outstanding 4.44B
Float 3.19B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 18
Average volume (90 days) 22
Price summary
52-Week low 8.85
52-Week high 16.2
Beta 0.35
50-Day moving average 10.25
200-Day moving average 11.47
Dividends and splits
Forward annual dividend rate 0.32
Forward annual dividend yield 0.0285%
Trailing annual dividend rate 11.7
Trailing annual dividend yield 1.0446%
5-Year annual dividend yield -
Payout ratio 0.09
Dividend Date 7 Apr 2026
Ex-Dividend Date 30 Mar 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.37%
Operating margin 0.62%
Operational effectiveness
Return on assets 0.19%
Return on equity 0.71%
Income Statement
Revenue (ttm) 43.86B
Revenue per share (ttm) 73.77
Quarterly revenue growth (yoy) 0.24%
Gross profit (ttm) 36.49B
EBITDA 181.54B
Net income to common (ttm) 16.32B
Diluted EPS (ttm) 3.67
Quarterly earnings growth (yoy) 0.67%
Balance Sheet
Total cash (mrq) 2.89B
Total cash per share (mrq) 4.87
Total debt (mrq) 19.59B
Total Debt/Equity (mrq) 72.09
Current ratio (mrq) 0.79%
Book value per share (mrq) 6.11
Cash Flow
Cash flow statement 15.85B
Levered free cash flow (LFCF) -1.61B
